scholarly journals CRT-100.93 To Evaluate Safety and Efficacy of Novel Sirolimus-Eluting Stent (DES+DCB) and Sirolimus-Coated Balloon for Treatment of Patients With Diabetes Mellitus

2020 ◽  
Vol 13 (4) ◽  
pp. S26
Author(s):  
Luca Testa ◽  
Sameer Dani
2011 ◽  
Vol 4 (4) ◽  
pp. 452-459 ◽  
Author(s):  
Steffen Desch ◽  
Denis Schloma ◽  
Sven Möbius-Winkler ◽  
Sandra Erbs ◽  
Stephan Gielen ◽  
...  

2007 ◽  
Vol 97 (2) ◽  
pp. 105-109 ◽  
Author(s):  
Frank D. Weber ◽  
Henrik Schneider ◽  
Marcus Wiemer ◽  
Thomas Pfannebecker ◽  
Ulrich Tebbe ◽  
...  

2021 ◽  
Vol 96 (2) ◽  
pp. 85-91
Author(s):  
Se-Eun Kim ◽  
Byung-Su Yoo

Diabetes is one of the important risk factors in cardiovascular disease associated with atherosclerosis, and cardiovascular disease is the leading cause of death in patients with diabetes mellitus. Recent randomized placebo-controlled cardiovascular outcome trials of all new antidiabetic drugs have linked SGLT-2 inhibitors and GLP1-agonists to not only increased cardiovascular stability but significant reduction of cardiovascular disease. These results have led to preferential selection of the most effective and beneficial antidiabetic drugs with the evidence of cardiovascular safety and efficacy. Herein, we address cardiovascular stability and the effectiveness of antidiabetic drugs, focusing on recently developed ones.


2016 ◽  
Vol 7 (5) ◽  
pp. 5
Author(s):  
LongChiau Ming ◽  
SitiSyarihan Abdullah ◽  
AliSaleh Alkhoshaiban ◽  
Vasudevan Mani ◽  
MuhammadEid Akkawi

PLoS ONE ◽  
2014 ◽  
Vol 9 (11) ◽  
pp. e111178 ◽  
Author(s):  
Katharina Hellhammer ◽  
Tobias Zeus ◽  
Jan Balzer ◽  
Silke van Hall ◽  
Christos Rammos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document